305 related articles for article (PubMed ID: 16945063)
1. Risk versus benefit considerations for the beta(2)-agonists.
Kelly HW
Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
[TBL] [Abstract][Full Text] [Related]
2. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
Dalonzo GE
J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
[TBL] [Abstract][Full Text] [Related]
3. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
5. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
6. What is new with the beta2-agonists: issues in the management of asthma.
Kelly HW
Ann Pharmacother; 2005 May; 39(5):931-8. PubMed ID: 15811904
[TBL] [Abstract][Full Text] [Related]
7. Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.
Colucci R; Fornai M; Tuccori M; Antonioli L; Pasqualetti G; Blandizzi C; Del Tacca M
J Asthma; 2007; 44(6):411-22. PubMed ID: 17654125
[TBL] [Abstract][Full Text] [Related]
8. Levalbuterol: pharmacologic properties and use in the treatment of pediatric and adult asthma.
Berger WE
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):583-91; quiz 591-2, 659. PubMed ID: 12839314
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
Kim D; Glaum M; Lockey R
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of B2-agonists action and safety aspects].
Chorostowska-Wynimko J
Pol Merkur Lekarski; 2002 Jun; 12(72):441-4. PubMed ID: 12362656
[TBL] [Abstract][Full Text] [Related]
11. Current options in the treatment of acute bronchospasm.
Berger WE
Postgrad Med; 2005 Dec; 118(6 Suppl Acute):18-26. PubMed ID: 19667712
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
13. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.
Donohue JF; Hanania NA; Ciubotaru RL; Noe L; Pasta DJ; Schaefer K; Claus R; Andrews WT; Roach J
Clin Ther; 2008; 30 Spec No():989-1002. PubMed ID: 18640474
[TBL] [Abstract][Full Text] [Related]
14. Inhaled beta agonists.
Op't Holt TB
Respir Care; 2007 Jul; 52(7):820-32. PubMed ID: 17594727
[TBL] [Abstract][Full Text] [Related]
15. Safety of long-acting beta2-agonists in the treatment of asthma.
Cazzola M; Matera MG
Ther Adv Respir Dis; 2007 Oct; 1(1):35-46. PubMed ID: 19124346
[TBL] [Abstract][Full Text] [Related]
16. Long-and short-acting beta 2-adrenergic agonists. Effects on airway function in patients with asthma.
Busse WW
Arch Intern Med; 1996 Jul; 156(14):1514-20. PubMed ID: 8687259
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta2-adrenoceptor agonists: a smart choice for asthma?
Lipworth BJ
Trends Pharmacol Sci; 2007 Jun; 28(6):257-62. PubMed ID: 17466387
[TBL] [Abstract][Full Text] [Related]
18. Beta-2 adrenergic agonists: focus on safety and benefits versus risks.
Ortega VE; Peters SP
Curr Opin Pharmacol; 2010 Jun; 10(3):246-53. PubMed ID: 20452285
[TBL] [Abstract][Full Text] [Related]
19. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
Chen AM; Bollmeier SG; Finnegan PM
Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
[TBL] [Abstract][Full Text] [Related]
20. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
Norman P
Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
